drugset / Trial / NCT03132779

Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion

NCT03132779

NaSingle-groupOpen-labelTreatment

Summary

Evaluating the effect of intralipid on the natural killer cells

Timeline

Start
2017-05-01
Primary completion
2018-01-20
Completion
2018-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Intralipid Other / unclassified 18 mg